Familial Nasopharyngeal Carcinoma 6

More documents

Recommendations

Info

Management of Patients with Failure Following Definitive Radiation Therapy 251Yu KH, Leung SF, Tung SY, et al (2005) Survival outcome ofpatients with nasopharyngeal carcinoma with first local failure:a study by the Hong Kong <strong>Nasopharyngeal</strong> <strong>Carcinoma</strong>Study Group. Head Neck 27:397–405Zheng XK, Ma J, Chen LH, et al (2005) Dosimetric and clinicalresults of three-dimensional conformal radiotherapy forlocally recurrent nasopharyngeal carcinoma. RadiotherOncol 75:197–203
Page 2:
MEDICAL RADIOLOGYRadiation Oncology
Page 6:
Jiade J. Lu, MD, MBAAssociate Profe
Page 10:
PrefaceNasopharyngeal cancer is a u
Page 14:
Contents1 The Epidemiology of Nasop
Page 18:
The Epidemiology of Nasopharyngeal
Page 22:
Page 26:
Page 30:
Page 34:
10 M-S. Zeng and Y-X. Zengenvironme
Page 38:
12 M-S. Zeng and Y-X. Zengmedicinal
Page 42:
14 M-S. Zeng and Y-X. Zengloss and
Page 46:
16 M-S. Zeng and Y-X. ZengNPC sampl
Page 50:
18 M-S. Zeng and Y-X. Zengthe basal
Page 54:
20 M-S. Zeng and Y-X. Zengmultistep
Page 58:
22 M-S. Zeng and Y-X. ZengHui AB, L
Page 62:
24 M-S. Zeng and Y-X. ZengSnudden D
Page 66:
Molecular Signaling Pathways 3in Na
Page 70:
Molecular Signaling Pathways in Nas
Page 74:
Page 78:
Page 82:
Page 86:
Page 90:
Page 94:
Natural History, Presenting Symptom
Page 98:
Page 102:
Page 106:
Page 110:
Page 114:
Page 118:
54 P-J. Lou, W-L. Hsu, Y-C. Chien e
Page 122:
Page 126:
Page 130:
Page 134:
Page 138:
Page 142:
66 K. S. Lohobviously surmise that
Page 146:
68 K. S. LohTable 6.2. Causal assoc
Page 152:
Pathology of Nasopharyngeal Carcino
Page 156:
Page 160:
Page 164:
Page 168:
Page 172:
Imaging in the Diagnosis and Stagin
Page 176:
Page 180:
Page 184:
Page 188:
Page 192:
Page 196:
Page 200:
96 J-C. Linon the outcome. The aim
Page 204:
98 J-C. LinTable 9.1. Summary of pr
Page 208:
100 J-C. LinTable 9.2. Summary of p
Page 212:
102 J-C. Lintumor volume was found
Page 216:
104 J-C. Lin(Neel et al. 1984a; Nee
Page 220:
106 J-C. Linradiotherapy became hig
Page 224:
108 J-C. Linsis. However, the false
Page 228:
Page 232:
112 J-C. LinTable 9.6. Summary of o
Page 236:
114 J-C. LinTable 9.7. Summary of t
Page 240:
Page 244:
118 J-C. Lincontaining 59 NPC patie
Page 248:
120 J-C. Linpatients of three nonke
Page 252:
122 J-C. Linfactor for metastasis-f
Page 256:
124 J-C. LinTable 9.9. Prognostic i
Page 260:
126 J-C. LinTable 9.10. Prognostic
Page 264:
128 J-C. Linthat it may trigger the
Page 268:
130 J-C. LinChen Y, Liu MZ, Liang S
Page 272:
132 J-C. LinHwang CF, Cho CL, Huang
Page 276:
134 J-C. LinMa BB, Leung SF, Hui EP
Page 280:
136 J-C. LinWang CC (1991) Improved
Page 284:
138 R. Ove, R. R. Allison, and J. J
Page 288:
Page 292:
Page 296:
Page 300:
Page 304:
Drug Therapy for Nasopharyngeal Car
Page 308:
Page 312:
Page 316:
Page 320:
Page 324:
Page 328:
The Intergroup 0099 Trial for Nasop
Page 332:
Page 336:
Page 340:
Concurrent Chemotherapy-Enhanced Ra
Page 344:
Page 348:
Page 352:
Page 356:
Page 360:
Page 364:
Page 368:
Page 372:
184 A. W. M. Lee14.2Nonrandomized S
Page 376:
186 A. W. M. Leescheduled. With a m
Page 380:
188 A. W. M. LeeTable 14.2. Phase I
Page 384:
190 A. W. M. LeeLR-FFR was slightly
Page 388:
192 A. W. M. LeeLee AW, Lau WH, Tun
Page 392:
194 B. C. Gohthe similarly favorabl
Page 396:
196 B. C. GohLi Zhang, Chong Zhao,
Page 400:
198 L. Kong, J. J. Lu, and N. Leean
Page 404:
200 L. Kong, J. J. Lu, and N. Leetr
Page 408:
202 L. Kong, J. J. Lu, and N. LeeFi
Page 412:
Page 416:
Page 420:
208 L. Kong, J. J. Lu, and N. LeeTa
Page 424:
210 L. Kong, J. J. Lu, and N. Leevo
Page 428:
Selection and Delineation of Target
Page 432:
Page 436:
Page 440:
Page 444:
Page 448:
Page 452: Selection and Delineation of Target
Page 468: Post-treatment Follow-Up of Patient
Page 484: Management of Patients with Failure
Page 506: Surgery for Recurrent Nasopharyngea
Page 534: 268 Y. Guo and B. S. Glissonpalliat
Page 538: 270 Y. Guo and B. S. Glissonresulti
Page 542: 272 Y. Guo and B. S. Glisson11.4 mo
Page 546: 274 Y. Guo and B. S. GlissonHasbini
Page 550: 276 S. S. Lo, J. J. Lu, and L. Kong
Page 554:
278 S. S. Lo, J. J. Lu, and L. Kong
Page 558:
Page 562:
Page 566:
Page 570:
Page 574:
Page 578:
Page 582:
Page 586:
Page 590:
296 E. Ozyar and I. Ayanmetastasis,
Page 594:
298 E. Ozyar and I. Ayanmens (Lomba
Page 598:
300 E. Ozyar and I. Ayanchemotherap
Page 602:
302 E. Ozyar and I. AyanTable 23.1.
Page 606:
304 E. Ozyar and I. Ayanand 127 (96
Page 610:
306 E. Ozyar and I. Ayan(Hodgkin’
Page 614:
308 E. Ozyar and I. AyanChildren’
Page 618:
310 B. O’Sullivan and E. Yuthe ra
Page 622:
312 B. O’Sullivan and E. Yuin the
Page 626:
314 B. O’Sullivan and E. YuTable
Page 630:
316 B. O’Sullivan and E. YuFig. 2
Page 634:
318 B. O’Sullivan and E. Yudefine
Page 638:
320 B. O’Sullivan and E. YuFig. 2
Page 642:
322 B. O’Sullivan and E. YuLee CC
Page 646:
324 Subject Index- - hand-foot synd
Page 650:
326 Subject IndexInverse planning (
Page 654:
328 Subject IndexRadiosensitizer, 1
Page 658:
List of ContributorsRon R. Allison,
Page 662:
List of Contributors 333Shaojun Lin
Page 666:
Medical RadiologyDiagnostic Imaging
Page 670:
Medical RadiologyDiagnostic Imaging
show all

Familial Nasopharyngeal Carcinoma 6

Create successful ePaper yourself

Delete template?

Save as template?